春立医疗
(688236)
| 流通市值：11.17亿 | | | 总市值：54.04亿 |
| 流通股本：7929.47万 | | | 总股本：3.84亿 |
| 报告期 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 380,130,570.92 | 221,850,180.79 | 1,208,523,845.88 | 792,155,559.31 |
| 营业收入 | 380,130,570.92 | 221,850,180.79 | 1,208,523,845.88 | 792,155,559.31 |
| 二、营业总成本 | 304,028,844.65 | 164,450,441.62 | 911,961,036.54 | 607,002,161.57 |
| 营业成本 | 108,247,815.46 | 58,041,719.59 | 332,635,741.48 | 232,370,997.62 |
| 税金及附加 | 4,342,874.75 | 1,832,378.18 | 10,850,629.27 | 5,742,326.79 |
| 销售费用 | 111,481,168.8 | 63,145,976.61 | 383,140,145.99 | 233,751,182.69 |
| 管理费用 | 21,310,062.04 | 7,522,645.72 | 44,471,023.1 | 28,910,652.58 |
| 研发费用 | 67,659,413.06 | 34,991,868.71 | 157,445,504.26 | 114,743,907.65 |
| 财务费用 | -9,012,489.46 | -1,084,147.19 | -16,582,007.56 | -8,516,905.76 |
| 其中:利息费用 | 27,050.23 | - | 85,896.45 | 48,115.37 |
| 其中:利息收入 | 8,040,034.97 | 1,263,505.11 | 14,461,912.36 | 8,164,883.5 |
| 加:公允价值变动收益 | 4,670,205.47 | 1,380,799.84 | 9,610,896.66 | 7,071,744.6 |
| 加:投资收益 | 6,084,909.58 | 3,286,525.21 | 12,012,452.06 | 10,067,668.5 |
| 资产处置收益 | 39,213.61 | - | 3,904.6 | -549.43 |
| 资产减值损失(新) | -5,229,285.17 | -26,245.26 | -20,707,206.43 | -3,175,940.28 |
| 信用减值损失(新) | -5,794,060.61 | -5,451,806.83 | -4,315,237.96 | -8,302,884.2 |
| 其他收益 | 6,413,483.27 | 2,736,455.16 | 12,807,845.26 | 5,119,584.73 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 82,286,192.42 | 59,325,467.29 | 305,975,463.53 | 195,933,021.66 |
| 加:营业外收入 | 856,684.38 | 856,134.36 | 346,862.92 | 289,299.36 |
| 减:营业外支出 | 72,914.25 | 17,033 | 416,463.41 | 339,218.67 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 83,069,962.55 | 60,164,568.65 | 305,905,863.04 | 195,883,102.35 |
| 减:所得税费用 | 4,109,067.77 | 5,057,505.44 | 28,087,746.56 | 15,402,533.56 |
| 六、净利润 | 78,960,894.78 | 55,107,063.21 | 277,818,116.48 | 180,480,568.79 |
| 持续经营净利润 | 78,960,894.78 | 55,107,063.21 | 277,818,116.48 | 180,480,568.79 |
| 归属于母公司股东的净利润 | 79,026,078.82 | 55,199,616.28 | 277,824,014.12 | 180,622,954.88 |
| 少数股东损益 | -65,184.04 | -92,553.07 | -5,897.64 | -142,386.09 |
| (一)基本每股收益 | 0.21 | 0.14 | 0.72 | 0.47 |
| (二)稀释每股收益 | 0.21 | 0.14 | 0.72 | 0.47 |
| 九、综合收益总额 | 78,960,894.78 | 55,107,063.21 | 277,818,116.48 | 180,480,568.79 |
| 归属于母公司股东的综合收益总额 | 79,026,078.82 | 55,199,616.28 | 277,824,014.12 | 180,622,954.88 |
| 归属于少数股东的综合收益总额 | -65,184.04 | -92,553.07 | -5,897.64 | -142,386.09 |
| 公告日期 | 2024-08-31 | 2024-04-30 | 2024-03-29 | 2023-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |